Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00091624
Status:
COMPLETED
Last Update Posted:
2016-12-01
First Post:
2004-09-13
Brief Title:
A Study of Doxil Vincristine and Decadron DVd CC-5013 in Relapsed Refractory Multiple Myeloma MM
Sponsor:
Celgene Corporation
Organization:
Celgene Corporation
Organization Data
Organization:
Celgene Corporation
Class:
INDUSTRY
Study ID:
CC-5013-MM-011
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Celgene Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None